Bio-Path Holdings is Biotechnology in United States that focus on Path Holdings Inc business. Founded in 2007. They cover business area such as bio-Path Holdings Inc, a novel technology, systemic delivery, target specific protein inhibition, any gene product, disease, prexigebersen, Phase, clinical trial, acute myeloid leukemia, AML, combination, low-dose cytarabine, LDAC, decitabine, its other drug.
2007
( 17 years old in 2024 )
Path Holdings Inc
-
4710 Bellaire Boulevard
Suite 210
Bellaire, TX 77401
United States
Private
bio-Path Holdings Inca novel technologysystemic deliverytarget specific protein inhibitionany gene productdiseaseprexigebersenPhaseclinical trialacute myeloid leukemiaAMLcombinationlow-dose cytarabineLDACdecitabineits other drug
* We use standard office opening hours in near Bio-Path Holdings's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Bio-Path Holdings is Biotechnology business from United States that founded in 2007 (17 years old in 2024), Bio-Path Holdings business is focusing on Path Holdings Inc.
Bio-Path Holdings headquarter office and corporate office address is located in 4710 Bellaire Boulevard Suite 210 Bellaire, TX 77401 United States.
Bio-Path Holdings was founded in United States.
In 2024, Bio-Path Holdings is currently focus on Path Holdings Inc sector.
Above is snippet of Google Trends for "Path Holdings Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Bio-Path Holdings, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
